Citation: Jp. Mcguirk et al., HLA-MISMATCHED FAMILY DONOR TRANSPLANTS - A NOVEL STRATEGY AS CURATIVE THERAPY FOR PATIENTS WITH HEMATOLOGIC DISORDERS, The cancer journal from Scientific American, 4(5), 1998, pp. 278-286
Citation: La. Parsels et E. Chu, THE ROLE FOR TRANSLATIONAL CONTROL OF THE CELL-CYCLE, The cancer journal from Scientific American, 4(5), 1998, pp. 287-295
Citation: Aj. Nixon, BREAST-CONSERVING THERAPY IN PATIENT WITH AN INHERITED SUSCEPTIBILITYTO BREAST-CANCER, The cancer journal from Scientific American, 4(5), 1998, pp. 296-297
Authors:
HARROLD EV
TURNER BC
MATLOFF ET
PATHARE P
BEINFIELD M
MCKHANN C
WARD BA
HAFFTY BG
Citation: Ev. Harrold et al., LOCAL RECURRENCE IN THE CONSERVATIVELY TREATED BREAST-CANCER PATIENT - A CORRELATION WITH AGE AND FAMILY HISTORY, The cancer journal from Scientific American, 4(5), 1998, pp. 302-307
Citation: Ja. Haas et al., AN ANALYSIS OF AGE AND FAMILY HISTORY ON OUTCOME AFTER BREAST-CONSERVATION TREATMENT - THE UNIVERSITY-OF-PENNSYLVANIA EXPERIENCE, The cancer journal from Scientific American, 4(5), 1998, pp. 308-315
Authors:
PASS HA
SCHWARZ SL
WUNDERLICH JR
ROSENBERG SA
Citation: Ha. Pass et al., IMMUNIZATION OF PATIENTS WITH MELANOMA PEPTIDE VACCINES - IMMUNOLOGICAL ASSESSMENT USING THE ELISPOT ASSAY, The cancer journal from Scientific American, 4(5), 1998, pp. 316-323
Citation: T. Do et al., SALVAGE RADIOTHERAPY FOR BIOCHEMICAL AND CLINICAL FAILURES FOLLOWING RADICAL PROSTATECTOMY, The cancer journal from Scientific American, 4(5), 1998, pp. 324-330
Authors:
WADLER S
HAYNES H
ROZENBLIT A
HU XP
KALEYA R
WIERNIK PH
Citation: S. Wadler et al., SEQUENTIAL PHASE-II TRIALS OF FLUOROURACIL AND INTERFERON BETA(SER) WITH OR WITHOUT SARGRAMOSTIM IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, The cancer journal from Scientific American, 4(5), 1998, pp. 331-337
Citation: A. Jones et Al. Harris, NEW DEVELOPMENTS IN ANGIOGENESIS - A MAJOR MECHANISM FOR TUMOR-GROWTHAND TARGET FOR THERAPY, The cancer journal from Scientific American, 4(4), 1998, pp. 209-217
Citation: Sl. Green et Aj. Giaccia, TUMOR HYPOXIA AND THE CELL-CYCLE - IMPLICATIONS FOR MALIGNANT PROGRESSION AND RESPONSE TO THERAPY, The cancer journal from Scientific American, 4(4), 1998, pp. 218-223
Citation: Ee. Vokes et Am. Mauer, MULTIMODALITY THERAPY FOR ESOPHAGEAL CANCER - AN EMERGING ROLE, The cancer journal from Scientific American, 4(4), 1998, pp. 226-229
Authors:
KUERER HM
NEWMAN LA
BUZDAR AU
DHINGRA K
HUNT KK
BUCHHOLZ TA
BINKLEY SM
STROM EA
AMES FC
ROSS MI
FEIG BW
MCNEESE MD
HORTOBAGYI GN
SINGLETARY SE
Citation: Hm. Kuerer et al., PATHOLOGICAL TUMOR RESPONSE IN THE BREAST FOLLOWING NEOADJUVANT CHEMOTHERAPY PREDICTS AXILLARY LYMPH-NODE STATUS, The cancer journal from Scientific American, 4(4), 1998, pp. 230-236
Authors:
POSNER MC
GOODING WE
LANDRENEAU RJ
ROSENSTEIN MM
CLARKE MR
PETERSON MS
LEMBERSKY BC
Citation: Mc. Posner et al., PREOPERATIVE CHEMORADIOTHERAPY FOR CARCINOMA OF THE ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION, The cancer journal from Scientific American, 4(4), 1998, pp. 237-246
Authors:
OLEKSOWICZ L
BHAGWATI N
FERNANDEZ MD
SENO R
ETKIND P
Citation: L. Oleksowicz et al., PROGNOSTIC-SIGNIFICANCE OF PLATELET IMMUNORELATED GPIB EXPRESSION IN BREAST-CANCER, The cancer journal from Scientific American, 4(4), 1998, pp. 247-253
Authors:
WIERNIK PH
DUTCHER JP
EINZIG AI
SPARANO J
FRANK M
FRIEDENBERG W
Citation: Ph. Wiernik et al., MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE, The cancer journal from Scientific American, 4(4), 1998, pp. 254-260
Authors:
WADLER S
ATKINS M
KARP D
NEUBERG D
HAYNES H
DUTCHER JP
Citation: S. Wadler et al., CLINICAL-TRIAL OF WEEKLY INTENSIVE THERAPY WITH 5-FLUOROURACIL ON 2 DIFFERENT SCHEDULES COMBINED WITH INTERFERON ALPHA-2A AND FILGRASTIM INPATIENTS WITH ADVANCED SOLID TUMORS - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY P-Z991, The cancer journal from Scientific American, 4(4), 1998, pp. 261-268
Authors:
AJANI JA
FAIRWEATHER J
DUMAS P
PATT YZ
PAZDUR R
MANSFIELD PF
Citation: Ja. Ajani et al., PHASE-II STUDY OF TAXOL IN PATIENTS WITH ADVANCED GASTRIC-CARCINOMA, The cancer journal from Scientific American, 4(4), 1998, pp. 269-274
Citation: R. Nowak et Sj. Chrapusta, REGULATION OF TELOMERASE ACTIVITY IN NORMAL AND MALIGNANT HUMAN-CELLS, The cancer journal from Scientific American, 4(3), 1998, pp. 148-154
Citation: J. Naitoh et As. Belldegrun, INTERFERON AND KIDNEY CANCER - A PROMISE UNFULFILLED, The cancer journal from Scientific American, 4(3), 1998, pp. 155-156
Citation: Jc. Blasko et al., RADIOTHERAPEUTIC STRATEGIES IN THE MANAGEMENT OF CLINICALLY LOCALIZED, LOW-RISK PROSTATE-CANCER - SELECTION, RESULTS, AND THE SEARCH FOR ANSWERS, The cancer journal from Scientific American, 4(3), 1998, pp. 157-158
Citation: Mj. Zelefsky, EARLY-STAGE PROSTATE-CANCER - CONTROVERSIES, CONFUSION, AND DIFFICULTCHOICES, The cancer journal from Scientific American, 4(3), 1998, pp. 159-161
Authors:
SMALL EJ
WEISS GR
MALIK UK
WALTHER PJ
JOHNSON D
WILDING G
KUZEL T
BEJAMONDE A
PATON V
Citation: Ej. Small et al., THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH RECOMBINANT HUMAN GAMMA-INTERFERON, The cancer journal from Scientific American, 4(3), 1998, pp. 162-167